arrow
Y

Yi Chen

Shanghai Institute of Materia Medica
H指数:38
被引数:4,715

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-dose antiangiogenic multikinase inhibitor AL3810 synergizes with PD-1 blockade by reducing CSF1-driven MHC-IIint tumour-associated macrophages to optimize TIM-3+ CD8+ T-cell effector function

低剂量抗血管生成多靶点激酶抑制剂AL3810通过减少CSF1驱动的MHC-II<sup>int</sup>肿瘤相关巨噬细胞,与PD-1阻断协同作用以优化TIM-3<sup>+</sup> CD8<sup>+</sup> T细胞效应功能

2026-09-290
PRE
Discovery of Novel Tridentate Alkenyl Diacid Derivatives as Potent ATP Citrate Lyase Inhibitors for the Treatment of Hepatocellular Carcinoma

新型三齿烯基二酸衍生物作为强效ATP柠檬酸裂合酶抑制剂在治疗肝细胞癌中的应用发现

2025-07-160
PRE
Development of ASGR-Mediated Hepatocyte-Targeting Cytotoxic Drug Conjugates with CTSB-Cleavable Linkers Incorporating Succinimide and Succinic Acid Monoamide

基于ASGR介导的靶向肝细胞的细胞毒性药物偶联物的开发:整合琥珀酰亚胺和琥珀酸单酰胺的CTS B可切割连接子

2025-02-070
PRE
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas

发现新的BTK抑制剂S-016并确定治疗淋巴瘤 (包括BTK抑制剂耐药淋巴瘤) 的新策略

2024-06-040
PRE